Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Clinical Cardiology

woman giving subcutaneous self-injection in abdomen

Can Enoxaparin Be Used as a Bridge to Warfarin for Outpatients With LVADs?

Cleveland Clinic series supports its feasibility, especially with HeartMate 3

ventricular tachycardia

Ventricular Arrhythmia-Related Cardiac Arrest Rare After PCI for STEMI

Study identifies a cohort of low-risk patients, finds LVEF predicts late VT/VF in those at higher risk

heart showing obstructive cardiomyopathy

Mavacamten in the Real World: Study Demonstrates Safe Reduction in Eligibility for Septal Reduction Therapy

Logistic feasibility supported for treating obstructive HCM under the REMS program

photo of cardiologists working in a cardiac catheterization lab

New AHA Statement Clarifies Cath Lab Role in Out-of-Hospital Cardiac Arrest

Guidance on the often-fatal condition through an interventional cardiology lens

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

23-HVI-4003412_aorta-illustration_650x450

How the New ACC/AHA Guideline on Aortic Disease Is Starting to Shape Practice

Impacts include major emphases on multidisciplinary teams, shared decision-making

cardiac PET scan

PET/CT With Myocardial Blood Flow Effectively Screens for Cardiac Allograft Vasculopathy

Study validates a noninvasive alternative to invasive coronary angiography

22-HVI-3509429_obstructive-hypertrophic-cardiomyopathy_650x450

Advances in Hypertrophic Cardiomyopathy Therapy: VALOR-HCM May Be Just the Beginning

An abundance of promising studies are on the horizon

22-HVI-3276959_obstructive-HCM-strain-imaging_650x450

Mavacamten’s Effects Against Obstructive Hypertrophic Cardiomyopathy Persist Through 32 Weeks in VALOR-HCM

Latest results confirm and build on 16-week findings

Knowing the signs can save your life

How Autoimmune Disorders Impact Myocardial Infarction Treatment and Long-Term Outcomes

Largest study to date finds lower intervention rates, elevated long-term mortality

22-HVI-3167284_stroke-in-brain_650x450

Is It Time to Add ‘C’ for Cancer to the CHA2DS2 VASc Score?

Large data analysis finds cancer helps predict stroke risk in patients with atrial fibrillation

BackPage 2 of 4Next

Advertisement

Ad